DePuy Synthes receives FDA 510(k) clearance for lower extremity plating system
Click Here to Manage Email Alerts
Key takeaways:
- DePuy Synthes received FDA 510(k) clearance for its TriLEAP lower extremity plating system.
- The system is indicated for reduction, internal fixation and fusion of bones and bone fragments.
DePuy Synthes has received FDA 510(k) clearance for its TriLEAP lower extremity plating system for use in orthopedic foot and ankle surgery, according to a press release.
The TriLEAP system features contoured and conventional plates with multiple screws and instruments for reduction, internal fixation and fusion of bones and bone fragments, according to the release.
“As a leader in elective foot and ankle procedures, DePuy Synthes is dedicated to developing novel solutions tailored to the changing needs of both patients and surgeons,” Oray Boston, worldwide president of trauma, extremities, craniomaxillofacial, animal health and sports at DePuy Synthes, said in the release. “The development and clearance of the TriLEAP lower extremity anatomic plating system is a prime example of how we are maintaining our speed of innovation in the space to address unmet needs and help achieve the best possible outcomes for patients,” Boston said.
Read more about
Click Here to Manage Email Alerts